In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $484.01, marking a +0.11% move from the previous day. This change outpaced the S&P 500's 4.84% loss on the day. At the same time, ...

Biotech stocks toppled early Thursday after Trump announced broad global tariffs, including a 20% tariff on goods from Europe ...

President Trump yesterday announced a baseline tariff of 10% on all imported products and higher rates on certain countries ...

By continuing to keep medications and pharmaceutical ingredients safe from trade levies, Trump can ensure that his America ...

In a major relief for the Indian pharmaceutical industry, the U.S. administration has exempted pharmaceuticals from the ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $478.12, a high ...

Analysts' ratings for Alnylam Pharmaceuticals ALNY over the last quarter vary from bullish to bearish, as provided by 27 ...

Up to $3 billion in pharmaceuticals currently used in the United States (U.S.) depend on Canadian manufacturing, according to ...

Recursion Pharmaceuticals uses artificial intelligence (AI) in its proprietary operating system to match new compounds ...

According to IQVIATM sales data for the 12-month period ending January 2025, the Vancomycin Hydrochloride for Injection USP, ...

Continues advancing clinical trial for INSTASYL siRNA lead product candidate PH-7623rd Cohort now fully enrolled in on-going ...